6 and 12- month Drug Retention Rates and Treatment Outcomes in 941 Patients with Axial Spondyloarthritis Treated with Secukinumab in Routine Clinical Practice in 12 European Countries in the EuroSpA Research Collaboration Network

Brigitte Michelsen, J. Askling, C. Codreanu, H. Mann, A. G. Loft, M. Pombo-Suarez, Z. Rotar, T. Kvien, M. J. Santos, A. M. Hokkanen, F. Iannone, B. Gudbjornsson, F. Onen, L. Jacobsson, R. Ionescu, K. Pavelka, C. Sánchez-Piedra, M. Tomsic, J. Sexton, H. SantosJ. Österlund, A. Cauli, A. J. Geirsson, S. Akar, A. Ciurea, G. Jones, I. van der Horst-Bruinsma, Cecilie Cornelia Heegaard Brahe, Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Merete Lund Hetland

Original languageEnglish
Article number1822
JournalArthritis & Rheumatology
Volume71
Issue numberS10
Number of pages4
ISSN1537-2960
Publication statusPublished - 2019

Cite this